Comparative effectiveness research in localized prostate cancer treatment

Area of Science:

• Urology
• Oncology
• Health Services Research

Background:

• Prostate-specific antigen (PSA) testing has led to a rise in localized prostate cancer diagnoses.
• Current treatment paradigms for localized prostate cancer include surgery and radiation therapy.
• There is a lack of direct comparative evidence for treatments like surgery versus radiation or active surveillance.

Purpose of the Study:

• To address the uncertainty in optimal treatment selection for localized prostate cancer.
• To evaluate comparative effectiveness of different treatment strategies.
• To highlight the importance of quality of life as a patient-centered outcome.

Main Methods:

• Utilizing comparative effectiveness research methodologies.
• Analyzing observational cohorts and claims data.
• Employing simulation models for treatment comparisons.

Main Results:

• Comparative effectiveness research can compare treatments not directly studied in controlled trials.
• Real-world outcomes data can be captured to inform clinical decisions.
• Quality of life is a critical outcome given the indolent nature of prostate cancer and treatment risks.

Conclusions:

• Comparative effectiveness research is essential for informed decision-making in localized prostate cancer management.
• Further research is needed to directly compare surgery, radiation, and active surveillance.
• Patient-centered outcomes, particularly quality of life, should guide treatment choices.